ReviewDrug design, development and therapy2016

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.

Christina N Kontoghiorghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.